170846-74-9
中文名稱
CHPG
英文名稱
CHPG
CAS
170846-74-9
分子式
C8H8ClNO3
分子量
201.61
MOL 文件
170846-74-9.mol
更新日期
2026/06/08 20:08:44
170846-74-9 結(jié)構(gòu)式
基本信息
中文別名
化合物 T10809 英文別名
CHPG(RS)-2-CHLORO-5-HYDROXYPHENYLGLYCINE
α-amino-2-chloro-5-hydroxybenzeneacetic acid
Benzeneacetic acid, α-amino-2-chloro-5-hydroxy-
(RS)-2-chloro-5-hydroxyphenylglycine α-amino-2-chloro-5-hydroxybenzeneacetic acid
α-Amino-2-chloro-5-hydroxybenzeneacetic acid, (RS)-2-Chloro-5-hydroxyphenylglycine
CHPG價(jià)格(試劑級)
| 報(bào)價(jià)日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價(jià)格 |
| 2026/06/05 | HY-101364 | CHPG CHPG | 170846-74-9 | 5mg | 600元 |
| 2026/06/05 | HY-101364 | CHPG CHPG | 170846-74-9 | 10 mg | 960元 |
| 2026/06/05 | HY-101364 | CHPG CHPG | 170846-74-9 | 25 mg | 2100元 |
常見問題列表
生物活性
CHPG 是一個(gè)選擇性的 mGluR5 激動劑，并且通過 TSG-6/NF-κB 途徑減弱 BV2 小神經(jīng)膠質(zhì)細(xì)胞 SO2 誘導(dǎo)的氧化應(yīng)激和炎癥。 CHPG 通過 ERK 和 Akt 途徑在體外和體內(nèi)預(yù)防創(chuàng)傷性腦損傷 (TBI)。靶點(diǎn)
|
mGlu 5
|
NF-κB
|
ERK
|
Akt
|
體外研究
CHPG (10-500?μM; 24?hours) significantly increases the cell viability and decreases the LDH release after SO
2
derivatives treatment.
CHPG (0.5?mM; 30?mins ) protects BV2 cells against SO
2
-induced apoptosis.
CHPG (0.5?mM; 30?mins) treatment alone increases the expression of TSG-6 in both mRNA and protein levels.
Cell Viability Assay
| Cell Line: | BV2 microglial cells |
| Concentration: | 10, 50, 100 and 500?μM |
| Incubation Time: | 24?hours |
| Result: | Increased the cell viability. |
Apoptosis Analysis
| Cell Line: | BV2 microglial cells |
| Concentration: | 0.5?mM |
| Incubation Time: | 30?mins |
| Result: | Protected BV2 cells against SO 2 -induced apoptosis. |
Western Blot Analysis
| Cell Line: | BV2 microglial cells |
| Concentration: | 0.5?mM |
| Incubation Time: | 30?mins |
| Result: | Increased the expression of TSG-6 in both mRNA and protein levels. |
體內(nèi)研究
CHPG (injection; 250 nM; for 7 days) reduces significantly cerebral lesion volume.
| Animal Model: | Adult Sprague-Dawley male rats weighing 280-320 g |
| Dosage: | 250 nM |
| Administration: | Injection; for 7 days |
| Result: | Reduced significantly cerebral lesion volume. |